Epilepsy and inflammation in the brain: overview and pathophysiology

Area of Science:

• Neuroscience
• Immunology
• Pathology

Background:

• Growing evidence suggests brain inflammation contributes to epilepsy.
• Inflammatory mediators, including IL-1beta and HMGB1, are found in human and experimental epileptic tissues, primarily expressed by glial cells.
• Neurons and blood-brain barrier endothelial cells also participate in neuroinflammation.

Purpose of the Study:

• To explore the role of inflammatory processes in the development and chronicity of epilepsy.
• To investigate the expression and function of inflammatory mediators and their receptors in epileptogenic tissue.
• To identify novel glioneuronal communication pathways in epilepsy.

Main Methods:

• Analysis of inflammatory mediator and receptor expression in human and experimental epileptic brain tissue.
• Investigation of the effects of inflammatory molecules on seizure activity in experimental models.
• Examination of cellular sources and neuropathological correlates of inflammation in chronic epilepsy.

Main Results:

• Overexpression of inflammatory cytokines (e.g., IL-1beta) and danger signals (e.g., HMGB1, S100beta) by glia in epileptic tissue.
• Evidence of both autocrine and paracrine signaling by inflammatory mediators.
• Seizures can induce brain inflammation independently of cell loss.
• Inflammatory molecules like IL-1beta and HMGB1 demonstrate proconvulsant activity, lowering seizure threshold through interactions with neurotransmitter systems.

Conclusions:

• Inflammatory processes are integral to seizure etiopathogenesis and the establishment of chronic epileptic foci.
• Novel glioneuronal communication mechanisms involving inflammatory mediators are identified in epilepsy.
• These findings highlight inflammatory pathways as potential therapeutic targets for epilepsy treatment.